fremanezumab-vfrm 225 MG per 1.5 ML Prefilled Syringe

RxCUI: 2056695
RxNorm name: fremanezumab-vfrm 225 MG per 1.5 ML Prefilled Syringe
Display name: fremanezumab-vfrm 225 MG per 1.5 ML Prefilled Syringe
Full name: fremanezumab-vfrm 225 MG per 1.5 ML Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:09

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761089	Ajovy	fremanezumab-vfrm	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
AJOVY	FREMANEZUMAB-VFRM	Teva Pharmaceuticals USA, Inc.	98e344ea-5916-4947-b6f2-4a76ccc04b6b	2026-06-05	Warnings, Adverse reactions	Exact identifier rxcui: 2056695

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
98e344ea-5916-4947-b6f2-4a76ccc04b6b	fremanezumab-vfrm 225 MG per 1.5 ML Prefilled Syringe	SY	23	These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY. AJOVY ® (fremanezumab-vfrm) injection, for subcutaneous use Initial U.S. Approval: 2018	20250805
98e344ea-5916-4947-b6f2-4a76ccc04b6b	fremanezumab-vfrm 225 MG in 1.5 mL Prefilled Syringe	PSN	23	These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY. AJOVY ® (fremanezumab-vfrm) injection, for subcutaneous use Initial U.S. Approval: 2018	20250805
98e344ea-5916-4947-b6f2-4a76ccc04b6b	1.5 ML fremanezumab-vfrm 150 MG/ML Prefilled Syringe	SCD	23	These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY. AJOVY ® (fremanezumab-vfrm) injection, for subcutaneous use Initial U.S. Approval: 2018	20250805